| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |